Index of medicine substances

Botulinum toxin type B  •  Musculo-skeletal system | Muscle relaxants | Muscle relaxants, peripherally acting agents | Other muscle relaxants, peripherally acting agents (M03AX01)

Bovine bile + sodium salicylate + methenamine  •  Alimentary tract and metabolism | Bile therapy | Bile acids and derivatives (A05AAN1)

Brentuximab vedotin  •  Antineoplastic and immunomodulating agents | Other antineoplastic agents | Monoclonal antibodies (L01XC12)

Brexpiprazol  •  Nervous system | Antipsychotics | Other antipsychotics (N05AX16)

Brexucabtagen autoleucel  •  Antineoplastic and immunomodulating agents | Other antineoplastic agents | Antineoplastic cell and gene therapy (L01XL06)

Brigatinib  •  Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Anaplastic lymphoma kinase (ALK) inhibitors (L01ED04)

Brimonidine  •  Sensory organs | Antiglaucoma preparations and miotics | Sympathomimetics in glaucoma therapy (S01EA05)

Brimonidine + timolol  •  Sensory organs | Antiglaucoma preparations and miotics | Beta blocking agents (S01ED51)

Brinzolamide  •  Sensory organs | Antiglaucoma preparations and miotics | Carbonic anhydrase inhibitors (S01EC04)

Brinzolamide + brimonidine  •  Sensory organs | Antiglaucoma preparations and miotics | Carbonic anhydrase inhibitors (S01EC54)

Brinzolamide + timolol  •  Sensory organs | Antiglaucoma preparations and miotics | Beta blocking agents (S01ED51)

Brivaracetam  •  Nervous system | Antiepileptics | Antiepileptics | Other antiepileptics (N03AX23)

Brivudine  •  Antiinfectives for systemic use | Direct acting antivirals | Nucleosides and nucleotides excl. reverse transcriptase inhibitors (J05AB15)

Brolucizumab  •  Sensory organs | Ocular vascular disorder agents | Antineovascularisation agents (S01LA06)

Bromazepam  •  Nervous system | Anxiolytics | Benzodiazepine derivatives (N05BA08)

Bromelain proteolytic enzyme concentrate  •  Dermatologicals | Enzymes | Proteolytic enzymes (D03BA03)

Bromfenac  •  Sensory organs | Antiinflammatory agents | Antiinflammatory agents, non-steroids (S01BC11)

Bromhexine  •  Respiratory system | Expectorants, excl. combinations with cough suppressants | Mucolytics (R05CB02)

Bromocriptine  •  Nervous system | Dopaminergic agents | Dopamine agonists (N04BC01)

Budesonide  •  Respiratory system | Other drugs for obstructive airway diseases, inhalants | Glucocorticoids (R03BA02)

Budesonide + formoterol  •  Respiratory system | Adrenergics, inhalants | Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics (R03AK07)

Bufexamac + bismuth subgallate + titanium dioxide + lidocaine  •  Cardiovascular system | Agents for treatment of hemorrhoids and anal fissures for topical use | Other agents for treatment of hemorrhoids and anal fissures for topical use (C05AX03)

Buformin  •  Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Biguanides (A10BA03)

Bulevirtide  •  Antiinfectives for systemic use | Direct acting antivirals | Other antivirals (J05AX28)

Bupivacaine  •  Nervous system | Anesthetics | Anesthetics, local | Amides (N01BB01)

Buprenorphine  •  Nervous system | Drugs used in addictive disorders | Drugs used in opioid dependence (N07BC01)

Buprenorphine + naloxone  •  Nervous system | Drugs used in addictive disorders | Drugs used in opioid dependence (N07BC51)

Bupropion  •  Nervous system | Antidepressants | Other antidepressants (N06AX12)

Burosumab  •  Musculo-skeletal system | Drugs affecting bone structure and mineralization | Other drugs affecting bone structure and mineralization (M05BX05)

Buspirone  •  Nervous system | Anxiolytics | Azaspirodecanedione derivatives (N05BE01)